- Challenging environment impacting revenue growth.
- Slow turnaround times impacting Q4 revenue in Europe.
- Ongoing absence of reimbursement and tightening economic environment in Asia Pacific.
- US FDA requested further information for Rest Assure®.
SomnoMed Limited
Greenhouse gas emissions & sustainability report data
Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 8.8478 tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.